Zom Pharmaceuticals

15 went up to more than 0. Zomedica Pharmaceuticals Corp. Company Overview More. The volatility of a stock over a given time period. Newsfile +22. , July 01, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. 73% on the last day (Friday, 3rd Sep 2021) from $0. News Corp is a global, diversified media and information services company focused on creating and distributing. Meanwhile, the Dow gained 0. Do the numbers hold clues to what lies ahead for the stock?. Zomedica Pharmaceuticals Corp Stock Earnings Report NYSE: ZOM. Gold Miners. Earnings date: 08/09/2021. The latest Tweets from Zomedica (@zomedica). Start Date: 07/15/2021 End Date: 12/31/1969. 16% over the past 2 weeks. A lot of people have dismissed ZOM as just another 'Reddit runner' or a 'meme' stock. Other News for ZOM Is Zomedica Stock Worth the Risk. Update, February 16: Zomedica Corp (NYSEAMERICAN: ZOM) shares face a significant test as traders return from a long weekend. On PennyStocks. Check out the pricing plans below. Investors may also find of interest. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Wainwright & Co. Stock Name. is not ranked # N/A. 0:00 / 3:04 •. This topic has been deleted. New comments cannot be posted and votes cannot be cast. (ZOM) Stock Sinks As Market Gains: What You Should Know 07/27/20-4:50PM EST Zacks. 3% from the previous trading session. ANN ARBOR, Mich. The company, currently valued at $86. 43%) Volume: 25. 02%) 52 Week High: $2. Real-time discussion about Zomedica Pharmaceuticals Corp. ZOM Zomedica Pharmaceuticals Corp — Stock Price and Discussion | Stocktwits. Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company was formerly known as Zomedica Pharmaceuticals Corp. erikgarduno14 last edited by. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. 6% success rate. Zomedica Pharmaceuticals Corp. Jun-25-20 09:26AM. com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles. (ZOM) closed the most recent trading day at $0. 0% Price as of September 1, 2021, 4:00 p. Overview Detailed Quote Charting Historical Prices. 16, moving -0. The stock price of Zomedica Corp (NYSEAMERICAN: ZOM) — a development stage veterinary diagnostic and pharmaceutical company that engages in the discovery, development, and commercialization of pharmaceuticals for pets — increased by 95. The stock kicked off with a bullish momentum and opened the session at $0. The Company is engaged in developing products for companion. 52wk Low 0. Ann Arbor, MI. Meanwhile, the Dow gained 0. Zomedica Pharmaceuticals Corp NYSEArca Updated Aug 19, 2021 8:00 PM. Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio; $ 599. Zomedica Pharmaceuticals Corp. 7m: Enterprise Value: £257. This is a momentous day for Zomedica ( ZOM ), our shareholders, the veterinarians we serve. Announces $30 Million Public Offering. Source: Postmodern Studio / Shutterstock. Zomedica Pharmaceuticals (NYSEMKT: ZOM ), an under-the-radar play on the pet care space, is having an impressive time in the stock market today. ZOM stock is known to experience high levels of volatility. , a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The average price target is $0. The day's price range saw the stock hit a low of $0. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. june 18 (reuters) - zomedica pharmaceuticals corp ::zomedica pharmaceuticals files prospectus relates to resale or other disposition of up to 23. The company report on August 10, 2020 that Zomedica Announces Second Quarter 2020 Financial Results. 3% from the previous trading session. Cash and equivalents of ~$62M as of Dec. (NYSE American: ZOM), (Zomedica or the Company), a veterinary health company, announced today that, in response to the COVID-19 crisis, it successfully implemented. The performance over the last five days has remained in the red territory. 24 below current price. 08/27/2021 04:09:37 PM. ZOM shares newsflow has stalled, slowing the impetus in the stock. - ZOM Stock Chart Technical Analysis for 05-28-2020Subscribe to My MAIN Channel Here: https://www. Press Release. August 26, 2021 by Joshua Rodriguez. You know volatility is a measure of oscillation (think a stock graph) of a stock against the average. 57% at the end of last trading. It offers products for dogs and. is a veterinary health company. Zomedica (ZOM) Stock Is Flying: Here's Why. 2078 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. ZOM has around 27. It offers. 91%) Official Closing Price Updated: 8:00 PM EDT, Aug 24, 2021 Add to My Watchlist. The lower-than-expected sales and market reach of Truforma, along with its declining financials, make pet stock Zomedica (ZOM) a weak investment now. The Bottom Line on ZOM Stock. Zomedica Pharmaceuticals Corp. Pessimistic target level: 0. Interactive chart for Zomedica Corp. 74% gain on the day. As we write this at 1:40 P. 4M compared to ~$0. Meanwhile. 34% above the 52 week low of 0. Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Mkt Cap 446. , is a development stage veterinary diagnostic and pharmaceutical company. 2021 is expected to be a huge year for penny stocks. Zomedica Pharmaceuticals Corp. 9 months ago. Stock Price, News and Company Updates. 11 from the previous close of $0. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. com/claytrader/Free. 16, moving -0. is a clinical-stage pharmaceutical company. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal. Sector Healthcare RiskRating. Since then, ZOM stock has increased by 188. ZOMEDICA PHARMACEUTICALS Key Stats, charts, historical data, comparisons and more at Zacks Advisor Tools. ZOM on Yahoo! Finance. (US:ZOM) with total holdings valued at $35,391,000 USD as of 2021-06-30. Bag held for ages and it did nothing but drop. EDT, ZOM was trading at $0. Zomedica Pharmaceuticals Corp (ZOM) stock is lower by -11. 5448 during the session. ZOMEDICA PHARMACEUTICALS Income Statement, Balance Sheet and Statement of Cash Flows. Find the latest Zomedica Corp. 86%) At close: 2 September 4:00PM EDT. 00% while ZOM has risen 9. , a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. During the day the stock fluctuated 4. Zomedica Pharmaceuticals Corp. Currency in USD. Biotechnology & Medical Research Zomedica Corp. 79% down from its year-to-date (YTD) trading value. 02 statement, which is an earnings press release pertaining to results of operations and financial condition. This change lagged the S&P 500's 0. 8-K Corporate News SEC Filings Under no circumstances does this report represent an endorsement to buy / sell these stocks. Investors may trade in the Pre-Market (4:00-9:30 a. Shares in Zomedica (ZOM) fall 8% in early Wednesday trading. Zomedica Pharmaceuticals (ZOM) share price, charts, trades & the UK's most popular discussion forums. 89% in the past month. 16, moving -0. + watchlist. The company's stock price has collected -15. 52wk High 2. 5820, rising 0. After all, ZOM stock cost less than 10 cents for much of 2020, and the share price is. Zomedica Pharmaceuticals Corp : ZOM. 0001171843-21-004627. Zomedica Pharmaceuticals Corp. The stock price of Zomedica Corp (NYSEAMERICAN: ZOM) — a development stage veterinary diagnostic and pharmaceutical company that engages in the discovery, development, and commercialization of pharmaceuticals for pets — is trading at over 45% today as of 2:16 PM ET. Heading into today, shares of the company had lost 28. Zomedica Pharmaceuticals Corp. Those who got in early and. 16% over the past 2 weeks. Provide free Zomedica(ZOM) transaction related announcements, including the company’s latest announcements on share acquisitions, spin-offs, repurchases, new shares issuance, bond and bill issuance, etc. ANN ARBOR, Mich. 0001171843-21-004411. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Zomedica Pharmaceuticals (ZOM - Research Report) today and set a price target of $1. During the day the stock fluctuated 4. - ZOM Stock Chart Technical Analysis for 05-28-2020Subscribe to My MAIN Channel Here: https://www. ZOM recent financial results. (NYSE:ZOM) has a beta value of -0. + watchlist. Zomedica Corp. Stocks with high levels of volatility are hard to time. SIC: PHARMACEUTICAL PREPARATIONS. as the stock recently outperformed the market by returning about 21. The stock's lowest day price was 0. Zomedica Pharmaceuticals Corp. The price has risen in 6 of the last 10 days and is up by 27. 16% over the past 2 weeks. 8% since the last quarter of 2020. Closes $20 Million Public Offering. Zomedica Corp. Find the latest ZOM stock news. Jul 02, 2020 · ANN ARBOR, Mich. GROUP LEADERSHIP. Description: Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. For financial reporting, their fiscal year ends on December 31st. Add any text here or remove it. Zomedica Announces 2021 Annual Meeting Results. State Street Corp Holds 18,366,408 BlackRock Holds 17,325,384 Renaissance Technology Holds 13,371,960 SPDR S&P Pharmaceuticals ETF Holds 13,091,502 Cambridge Investment Holds 11,143,288 Geode Capital Management Holds 7,881,629 FSMAX Fidelity Holds 7,285,929. Company Overview More. Meanwhile, the Dow gained 0. (NYSE American: ZOM), (“Zomedica” or. is regulated by the U. Data sources include IBM Watson Micromedex (updated 31 Aug 2021), Cerner Multum™ (updated 1 Sep 2021), ASHP (updated 30 Aug 2021. Is Zomedica Pharmaceuticals Corp. Press Release reported on 04/08/21 that Thinking about buying stock in Safe-T Group, S. , July 01, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. PCG Research Announces Publication of Update Report Covering Zomedica Pharmaceuticals Corp. The stock went to a low of $0. Zomedica is creating health and wellness solutions for companion animals by focusing on the unmet needs of clinical veterinarians. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. 6002 USD +0. 4 cloud your judgment. Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. NEW YORK, Feb. 81% Upvoted. Zomedica Pharmaceuticals (ZOM) share price, charts, trades & the UK's most popular discussion forums. 89% in the past month. 74% gain on the day. ZOM has around 27. Zomedica Announces Second Quarter 2021 Financial Results. 57% at the end of last trading. 00% while ZOM has risen 9. ZOM on TradingView. Participation from Market Makers and ECNs is strictly voluntary and as a result, these. Cumberland Pharmaceuticals 14-Day RSI as of today (September 11, 2021) is 42. 86%) At close: 2 September 4:00PM EDT. Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts. 03/08/2021 14:52:58 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Instantly ZOM has showed a red trend with a performance of -0. Quarterly Reports Insider Filings Other Filings. The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. Stock analysis for Zomedica Corp (ZOM:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Jun-30-20 09:00AM. The Company is developing point-of-care diagnostic. (ZOM) closed at $0. Zomedica Corp is primarely in the business of pharmaceutical preparations. Zomedica Pharmaceuticals (NYSEMKT: ZOM) stock is the latest pump-and-dump looking to take investors for a ride. The company has operations primarily in the U. Zomedica Corp. Zomedica Pharmaceuticals (ZOM): Q2 GAAP EPS of -$0. Participation from Market Makers and ECNs is strictly voluntary and as a result, these. 08/26/2021 04:08:16 PM. The price has risen in 6 of the last 10 days and is up by 27. Quarterly Reports Insider Filings Other Filings. (NYSE American: ZOM) announced Monday morning that Shameze Rampertab has resigned as CFO and as a member of the company's board of directors, effective Aug. ZOM:ASQ price moved over -1. (ZOM) AMEX. Zomedica Pharmaceuticals Corp. 43%, and the Nasdaq, a tech-heavy index, added 1. 48%) 08-29 14:57 Open: 0. The Company is engaged in. 03 from the previous closing price of $0. (NYSE American: ZOM) announced Monday morning that Shameze Rampertab has resigned as CFO and as a member of the company's board of directors, effective Aug. This is a -1. Pay yearly (Save 44 %) Pay monthly. Share your opinion and gain insight from other stock traders and investors. (US:ZOM) with total holdings valued at $35,391,000 USD as of 2021-06-30. 6216 Sep 03 2021 Key statistics On Wednesday, Zomedica Corp (ZOM:ASQ) closed at 0. ZOM News: High volatility in Zomedica Pharmaceuticals Corp stock price on Thursday which ended trading at $0. The average price we get from analysts is $0. Previously driven by intense meme pressure, ZOM stock found itself providing blistering returns before it all went sour. 81% of US stocks. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart. Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts. 4M compared to ~$0. In fact, one big catalyst has. View which stocks have been most impacted by COVID-19. Zomedica Corp. To see how InvestorsObserver's proprietary scoring system rates these. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) www. com is prohibited. 30 expecting ZOM to fall to within 12 months. ETF market. Zomedica's product portfolio will. The stock price of Zomedica Corp (NYSEAMERICAN: ZOM) is trading at over 45% as of 2:16 PM ET today. look at Zom which had $0 revenue in 2020. Meanwhile. About the Zomedica Corp. 2021-08-13 - Vanguard Group Inc has filed a 13F-HR form disclosing ownership of 42,501,241 shares of Zomedica Pharmaceuticals Corp. Exchange: AMEX ->Drug Manufacturers General Specialty & Generic. The company, which focuses on pet health, has been a. 5% success rate. 1m 3m 6m YTD 1y 2y 5y. Symbol: Last Trade: Date: Change: Open: High: Low: Volume: ZOM: 0. ZOM - Zomedica Pharmaceuticals Share Price. The stock went to a low of $0. ZOM News: High volatility in Zomedica Pharmaceuticals Corp stock price on Thursday which ended trading at $0. ANN ARBOR, Mich. Speculative. (AMEX:ZOM) shares, rose in value on Thursday, 08/12/21, with the stock price down by -7. Zomedica Pharmaceuticals Corp. 97% from a day low at $0. Revenue for the three months ended June 30, 2021 was $15,693. The stock went to a low of $0. (ZOM) Stock Sinks As Market Gains: What You Should Know. This makes Zomedica Pharmaceuticals the world's 4293th most valuable company by market cap according to our data. Free forex prices, toplists, indices and lots more. Zomedica Pharmaceuticals (NYSEMKT: ZOM ), an under-the-radar play on the pet care space, is having an impressive time in the stock market today. 60 to a day high of $0. To see how InvestorsObserver's proprietary scoring system rates these. 24%, while the tech-heavy Nasdaq added 0. (ZOM) Stock Sinks As Market Gains: What You Should Know 07/27/20-4:50PM EST Zacks. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog. [AMEX: ZOM] jumped around 0. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Your always. was founded in 2015 and is headquartered in Ann Arbor, Michigan. Ann Arbor, Michigan 48108. 93% shares climbed 42. 3M shares in the U. 39 at the end of this 3-month period. 1 st in group. ZOM Stock Trend. Zomedica Pharmaceuticals Corp. Instantly ZOM has showed a red trend with a performance of -0. Update, February 16: Zomedica Corp (NYSEAMERICAN: ZOM) shares face a significant test as traders return from a long weekend. ZOM - Zomedica Corp. Edit Profile. 16, marking a +0. Some companies that are related to Zomedica Pharmaceuticals Corp. 26% while the S&P 500 is unchanged 0% as of 2:36 PM on Tuesday, Jun 30. 09, close to its 52-week low of $0. 52wk Low 0. (NYSE American: ZOM) ("Zomedica" or the. (ZOM) Stock Sinks As Market Gains: What You Should Know. Company Overview More. Zomedica Pharmaceuticals Corp. The stock has declined recently. The company report on August 10, 2020 that Zomedica Announces Second Quarter 2020 Financial Results. However, the truth couldn't be further. ZOM is more like a pharmaceutical play for me. The Company is engaged in developing products for companion. Zomedica (ZOM), which develops diagnostic and pharmaceutical products for companion animals, saw little share price fluctuation over the past few years until the penny stock soared after being promoted. 6% success rate. 11 and lowest of $0. Ramakanth covers the Healthcare sector, focusing on stocks such. 61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. (ZOM) Stock Sinks As Market Gains: What You Should Know 07/27/20-4:50PM EST Zacks. It offers products for dogs and. The company is also developing. (NYSE:PFE) today announced the initiation of RENOIR ( R SV vaccine E fficacy study i N O lder adults I mmunized. Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), ("Zomedica" or. 16, marking a +0. 3m: Revenue: £21. The stock price of Zomedica Corp (NYSEAMERICAN: ZOM) — a development stage veterinary diagnostic and pharmaceutical company that engages in the discovery, development, and commercialization of pharmaceuticals for pets — increased by 95. Stock added 924,713 shares. Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV). Zomedica Pharmaceuticals Corp (ZOM) delivered earnings and revenue surprises of 0. 79% down from its year-to-date (YTD) trading value. (NYSE: ZOM) Another penny stock that investors have been watching recently is Zomedica Corp. com Zomedica Is Good Value and May Be Worth $1. Meanwhile, the Dow gained 0. Zomedica Pharmaceuticals Corp. Zomedica Corp. Pessimistic target level: 0. The Zomedica Pharmaceuticals Corp stock price fell by -4. com, Ramakanth is a 5-star analyst with an average return of 35. In the past month, shares of ZOM stock have increased by over 5%, bringing its YTD gain to over 68%. Heading into today, shares of the company had lost 28. Official notification to shareholders of matters to be brought to a vote ("Proxy") Proxy Filings. We focus on developing small molecules and biologics to treat CNS (pain, neurology, psychiatry, addiction) and. Targeted Therapies for Patients with Unmet Needs. Announces $30 Million Public Offering. 16, moving -0. Zomedica Pharmaceuticals Corp. More Zacks News for ZOM. "Zomedica Pharmaceuticals Corp. is a veterinary health company. ZOM stock is known to experience high levels of volatility. 5, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, NOK, ZYNE, SENS, and ATOS. Investors may trade in the Pre-Market (4:00-9:30 a. Participation from Market Makers and ECNs is strictly voluntary and as a result, these. Zomedica Corp. The Second Half of 2021 Should Be Much Easier for Zomedica Investors. and changed its name to Zomedica Corp. Traders who pay close attention to intraday price movement should know that it fluctuated between $0. 949% volatility is expected. ET View Interactive ZOM Charts. Company Overview More. ZOM Stock Trend. ZOM's price/sales ratio is 15,508. 74% gain on the day. 1 Zomedica Pharmaceuticals Corp (ZOM) 10 Year Volatility. 933% volatility is expected. Closes $20 Million Public Offering. 58 share on AMEX. Cumberland Pharmaceuticals 14-Day RSI as of today (September 11, 2021) is 42. 933% volatility is expected. ZOM's price/sales ratio is 15,508. Two more institutions adding into the Zom family today. Ann Arbor, MI. Actinium is developing a pipeline of Antibody Radiation Conjugates for targeted conditioning and combination therapies. Zomedica Corp. Zomedica Pharmaceuticals Corp (ZOM) Company Description Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Learn about ZOM (XASE) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in various therapeutic areas, including respiratory disease, allergy and opioid overdose. Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual. Zomedica Announces Second Quarter 2021 Financial Results. 6125: Sept-01-2021-0. The volatility of a stock over a given time period. 10 at the close of the session, up 42. Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Zomedica (ZOM) Stock Is Flying: Here's Why. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. 00% while ZOM has risen 9. com is prohibited. Animal lovers, unite! Zomedica Pharmaceuticals (NYSEMKT: ZOM), an under-the-radar play on the pet care space, is having an impressive time in the stock market today. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Zomedica Pharmaceuticals (ZOM - Research Report) today and set a price target of $0. 72% gain on the day. - ZOM Stock Chart Technical Analysis for 05-28-2020Subscribe to My MAIN Channel Here: https://www. 3M shares in the U. com - Mon Jun 7, 3:08PM CDT. Meanwhile, the Dow gained 0. The company engages in the development and commercialization of TRUFORMA, a diagnostic biosensor platform for the detection of. Zomedica Pharmaceuticals Corp (NY: ZOM ) 0. + watchlist. 57%) Forget Zomedica, Buy These 2 Pet Stocks Instead stocknews. Zomedica Pharmaceuticals Has to Prove Itself to Long-Term Investors Jun. Zomedica net profit margin as of June 30, 2021 is 0%. Stock Snapshot. Current P/E ratio: 0 | Price (September 07, 2021, EOD): $0. The company's shares closed last Thursday at $0. To see how InvestorsObserver's proprietary scoring system rates. Zomedica Pharmaceuticals Corp. Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV). (ZOM) Stock Sinks As Market Gains: What You Should Know. 7k: Position in Universe: th / 2694 Quality. 93% shares climbed 42. com : disclaimers Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews. Zomedica Pharmaceuticals Corp Stock Earnings Report NYSE: ZOM. 02 and has seen 35,041,724 shares traded in the last trading session. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis. documents---0. Zomedica Pharmaceuticals Corp. 02 statement, which is an earnings press release pertaining to results of operations and financial condition. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. Heading into today, shares of the company had lost 28. Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. 26% while the S&P 500 is unchanged 0% as of 2:36 PM on Tuesday, Jun 30. [email protected] According to TipRanks. Jul 02, 2020 · ANN ARBOR, Mich. 23% increase in ownership of ZOM / Zomedica Pharmaceuticals Corp. Instagram, Twitter, Facebook, TikTok, Images and more on IDCrawl - the leading free people search engine. 56 and touched an intraday high of $0. (ZOM) closed the most recent trading day at $0. 02%) 52 Week High: $2. It offers products for dogs and. 70% intraday to trade at $0. 02/09/2021 18:20:58 1-888-992-3836 Free Membership Login. Actinium is developing a pipeline of Antibody Radiation Conjugates for targeted conditioning and combination therapies. Meanwhile, the Dow gained 0. Zomedica Corp. About ZOM Zomedica Corp. Revenue for the three months ended June 30, 2021 was $15,693. 17/08/2021 15:51:50 1-888-992-3836 Free Membership Login. Get the latest Zomedica Corp (ZOM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 81% of US stocks. ZOMEDICA PHARMACEUTICALS Income Statement, Balance Sheet and Statement of Cash Flows. (ZOM) NYSE American - NYSE American Delayed price. Ann Arbor, MI. and changed its name to Zomedica Corp. 57% move from the previous day. Zomedica Pharmaceuticals (ZOM): Q2 GAAP EPS of -$0. This is a -1. On the front-facing side of things, you might not find a better no-brainer (albeit highly speculative) narrative than Zomedica (NYSEAMERICAN:ZOM), the veterinary care specialist focusing on diagnostics platforms. View our Recent Webinar (Now Available On Demand) Latest News More News View RACE-Approved Webinars. Gold Miners. + watchlist. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog. Has anybody invested in ZOM yet? 18 comments. (ZOM) stock discussion in Yahoo Finance's forum. Cut losses this week and haven't looked back tbh. 23% increase in ownership of ZOM / Zomedica Pharmaceuticals Corp. It is focused on developing three diagnostic platforms, a Bulk. ZOM's price/sales ratio is 15,508. The best long-term & short-term Zomedica share price prognosis for 2021. It would be an exaggeration to claim that every investor in Zomedica is disappointed. Zomedica Pharmaceuticals Corp : ZOM. Cash and equivalents of ~$62M as of Dec. Stocks of the Ann Arbor, Michigan-based pharmaceutical firm dipped by 3. Zomedica Pharmaceuticals Corp. Cumberland Pharmaceuticals 50-Day SMA as of today (September 11, 2021) is €2. com Unlike other meme. Kitov Pharmaceuticals NASDAQ Updated Sep 7, 2021 3:32 PM. This change lagged the S&P 500's 0. KTOV Kitov Pharmaceuticals — Stock Price and Discussion | Stocktwits. 43%) Volume: 25. 74% gain on the day. Zomedica (ZOM), which develops diagnostic and pharmaceutical products for companion animals, saw little share price fluctuation over the past few years until the penny stock soared after being promoted. Meanwhile, the Dow gained 0. 43%) Volume: 25. The company has operations primarily in the U. Stock Price, News and Company Updates. Detailed financial statements for Zomedica stock (ZOM), including the income statement, balance sheet, and cash flow statement. 4 cloud your judgment. [email protected] The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. Your always. 39% of US stocks. Moreover, significant losses can happen over a very short period of time. (NYSE American: ZOM) announced Monday morning that Shameze Rampertab has resigned as CFO and as a member of the company's board of directors, effective Aug. 10 at the close of the session, up 42. Press Release reported on 04/08/21 that Thinking about buying stock in Safe-T Group, S. Zomedica Pharmaceuticals Corp (NY: ZOM ) 0. Shares in Zomedica (ZOM) fall 8% in early Wednesday trading. The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. Zomedica Pharmaceuticals Corp. 5448 during the session. Market capital became more than $3 billion at one point with 0 revenue. 16% over the past 2 weeks. [AMEX: ZOM] jumped around 0. The Company is engaged in. Estimated Average Forecasted Zomedica Price: 0. ZOM: Get the latest Zomedica stock price and detailed information including ZOM news, historical charts and realtime prices. 35 per share, ZOM stock soared to a high of $2. To see how InvestorsObserver's proprietary scoring system rates. ZOM updated stock price target summary. 15 went up to more than 0. Cumberland Pharmaceuticals 50-Day SMA as of today (September 11, 2021) is €2. 74% gain on the day. Follow along and learn as I perform a quick stock chart technical analysis review on the Zomedica Corp. 97%) ELAN : 33. Your always. ETF market. Sp went up from $0,1 to $3. KTOV Kitov Pharmaceuticals — Stock Price and Discussion | Stocktwits. 72% gain on the day. 02/09/2021 18:20:58 1-888-992-3836 Free Membership Login. (ZOM) July 22, 2020; Trade Setup. View which stocks have been most impacted by COVID-19. 39 at the end of this 3-month period. Zomedica Announces First Quarter 2021 Financial Results. The Company's drug development programs are directed toward disorders affecting the central nervous system (CNS. Biotechnology & Medical Research Zomedica Corp. View our Recent Webinar (Now Available On Demand) Latest News More News View RACE-Approved Webinars. This change lagged the S&P 500's 0. Stock added 924,713 shares. Revenue for the three months ended June 30, 2021 was $15,693. 81% of US stocks. Sign up for Newsletter. 57%) Volume: 867. [AMEX: ZOM] closed the trading session at $0. To see how InvestorsObserver's proprietary scoring system rates. Company Profile. 86% during the next 3 months and, with a 90% probability hold a price between $0. 58 share on AMEX. 02 and has seen 35,041,724 shares traded in the last trading session. Zomedica Pharmaceuticals Corp. The P/E ratio of Zomedica Pharmaceuticals Corp. Zomedica net profit margin as of June 30, 2021 is 0%. The mission of Adamis is to provide high quality, lower-cost alternatives to existing therapies in various. Security and Exchange Commission and incorporated in the state of Alberta, Canada. 8% and is now trading at $0. Dow Jones, a News Corp company About WSJ. ZOM reported revenue of $15,693 for Q2 2021. ANN ARBOR, Mich. The company engages in the development and commercialization of TRUFORMA, a diagnostic biosensor platform for the detection of thyroid disorders in dogs and cats, and adrenal disorders in dogs. ZOM's stock price has gained 260% over the past year. Market Cap. Overall Average: 72% Sell. CA, an investment chat community for Canada's small cap markets. Zomedica Pharmaceuticals Corp. To see how InvestorsObserver's proprietary scoring system rates. 74% gain on the day. NEW YORK, June 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, NSPR, GE, NCLH, and EVFM. - ZOM Stock Chart Technical Analysis for 05-28-2020Subscribe to My MAIN Channel Here: https://www. , formerly Zomedica Pharmaceuticals Corp. More analysis for REGN. Zomedica Pharmaceuticals Corp. The company's stock price has collected -15. The market capitalization, commonly called market cap, is the total. Find real-time SLRX - Salarius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. “Zomedica Pharmaceuticals Corp. 5094 USD +0. Zomedica Pharmaceuticals Has to Prove Itself to Long-Term Investors Jun. Sp went up from $0,1 to $3. (NYSE American: ZOM) (“Zomedica” or the. (ZOM) closed the most recent trading day at $0. 56 and touched an intraday high of $0. It offers products for dogs and. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. ZOM is down -$0. Targeted Therapies for Patients with Unmet Needs. This makes Zomedica Pharmaceuticals the world's 4293th most valuable company by market cap according to our data. After all, ZOM stock cost less than 10 cents for much of 2020, and the share price is. 58 (Find current average P/E ratios for all sectors below ). 02 and has seen 35,041,724 shares traded in the last trading session. 26 on volume of 66,906,464 shares. , is based in Ann Arbor, Michigan. Symbol: Last Trade: Date: Change: Open: High: Low: Volume: ZOM: 0. Investment differs by a margin of $2 million. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing of its previously announced public offering of 187,500,000 common shares (or common share equivalents) of the Company, together with short-term warrants to purchase up to 187,500,000 common shares, at a combined public offering price of $0. 11 and lowest of $0. More Zacks News for ZOM. 86%) At close: 2 September 4:00PM EDT. Zomedica Pharmaceuticals Corp. Zomedica Corp. Insider trades for Zomedica Corp. Official notification to shareholders of matters to be brought to a vote ("Proxy") Proxy Filings. Zomedica Pharmaceuticals Corp is a veterinary pharmaceutical and health care solutions company targeting products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical. Description: Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians.